Teladoc Health lost $13.7 billion in 2022, mostly from a write-off related to the plummeting value of Livongo. This experience should serve as a massive lesson to the rest of the healthcare business community. The health solution graveyard is littered with answers to problems that make sense, but fail to produce the promised results. The Teledoc-Livongo
Feb 27, 2023·edited Feb 27, 2023Liked by William H Bestermann Jr MD
Unsurprisingly shocking! American legacy medicine, I call it a "American Legacy Late-stage-sickness-seeking-profittering Kabuki Dance Theatre," or as Professor Lustig describes, "Fifty-year Wild Goose Chase," must be replaced.
Incidentally, what we have discovered is concurrent with the current understanding of the metabolic origins of most chronic illnesses. We provide the objective and quantitative physiological measurements missing in the conventional legacy work. We prove Professor Lustig's point perfectly; he doesn't know that yet. But he will!
Also, read his book "Metabolical." I am reading it. What we have discovered is not just coincidence; this is our destiny.
I declare the metabolic origin of all diseases will be our focus to help the missing information gap. The critical information we deliver will change the world through fundamental lifestyle metabolic optimization medicine.
Joseph T. Shen, Recovered Physician, Developer of The World's first BioCybernetic Computational Systems Physiology Technology Platform
All true commentary Bill. The biggest takeaway for me relates to the fact that Livongo, like historic wellness snap on plans, was a point solution that was never integrated into a patient’s own PCP or specialist. They operated on their own without coordinating care. Further, they rarely, if ever, integrated their utilization into the employer’s data/analytics to either show or not show ROI. Livongo isn’t the only point solution that has tried to sell direct to employer without any sort of coordination or accountability. It is a failed model. That realization was made clear in their own earnings call.
Unsurprisingly shocking! American legacy medicine, I call it a "American Legacy Late-stage-sickness-seeking-profittering Kabuki Dance Theatre," or as Professor Lustig describes, "Fifty-year Wild Goose Chase," must be replaced.
Incidentally, what we have discovered is concurrent with the current understanding of the metabolic origins of most chronic illnesses. We provide the objective and quantitative physiological measurements missing in the conventional legacy work. We prove Professor Lustig's point perfectly; he doesn't know that yet. But he will!
https://youtu.be/odZlKkGkOVI
Also, read his book "Metabolical." I am reading it. What we have discovered is not just coincidence; this is our destiny.
I declare the metabolic origin of all diseases will be our focus to help the missing information gap. The critical information we deliver will change the world through fundamental lifestyle metabolic optimization medicine.
Joseph T. Shen, Recovered Physician, Developer of The World's first BioCybernetic Computational Systems Physiology Technology Platform
Thanks Joseph. All the pieces are in place to dramatically improve health and reduce costs.
Yup! You are very welcome, Bill!
We are desiging our next generation technology platform to meet the anticipated higher demands! Stay tuned.
All true commentary Bill. The biggest takeaway for me relates to the fact that Livongo, like historic wellness snap on plans, was a point solution that was never integrated into a patient’s own PCP or specialist. They operated on their own without coordinating care. Further, they rarely, if ever, integrated their utilization into the employer’s data/analytics to either show or not show ROI. Livongo isn’t the only point solution that has tried to sell direct to employer without any sort of coordination or accountability. It is a failed model. That realization was made clear in their own earnings call.
Thank you so much for that important comment Jeff. We understand those gaps and we are determined to fill them. We just need willing partners.